Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
Journal of Women'S Health (2002)
|
February 28, 2020
Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort
Tina J Hieken, Amy E Glasgow, Elizabeth Ann L Enninga, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 25, 2005
Inability of bm14 mice to respond to Theiler's murine encephalomyelitis virus is caused by defective antigen presentation, not repertoire selection
Matthew S Block, Yanice V Mendez-Fernandez, Virginia P Van Keulen, et al.
Gynecologic Oncology
|
June 11, 2020
Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer
Deepa Maheswari Narasimhulu, Michaela E McGree, Amy L Weaver, et al.
Psycho-Oncology
|
June 24, 2015
Ureteral obstruction in cancer patients: a qualitative study
Amanika Kumar, Lance Mynderse, Krishna Patel, et al.
Gynecologic Oncology
|
July 28, 2024
Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial
Aditi Gupta, Roisin E O'Cearbhaill, Matthew S Block, et al.
Oncology
|
December 16, 2014
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients
Aminah Jatoi, Carmen Radecki Breitkopf, Nathan R Foster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 20, 2021
Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes
Francesco Multinu, Simone Garzon, Amy L Weaver, et al.
Gynecologic Oncology
|
June 15, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes
Riham Suleiman, Shilpa Mokshagundam, Matthew S Block, et al.
Melanoma Research
|
June 24, 2011
Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine
Matthew S Block, Vera J Suman, Wendy K Nevala, et al.
Frontiers in Immunology
|
February 19, 2025
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Yuan Yao, Yiyi Yan, Vera J Suman, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
Journal of Women'S Health (2002)
|
February 28, 2020
Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort
Tina J Hieken, Amy E Glasgow, Elizabeth Ann L Enninga, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 25, 2005
Inability of bm14 mice to respond to Theiler's murine encephalomyelitis virus is caused by defective antigen presentation, not repertoire selection
Matthew S Block, Yanice V Mendez-Fernandez, Virginia P Van Keulen, et al.
Gynecologic Oncology
|
June 11, 2020
Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer
Deepa Maheswari Narasimhulu, Michaela E McGree, Amy L Weaver, et al.
Psycho-Oncology
|
June 24, 2015
Ureteral obstruction in cancer patients: a qualitative study
Amanika Kumar, Lance Mynderse, Krishna Patel, et al.
Gynecologic Oncology
|
July 28, 2024
Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial
Aditi Gupta, Roisin E O'Cearbhaill, Matthew S Block, et al.
Oncology
|
December 16, 2014
A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients
Aminah Jatoi, Carmen Radecki Breitkopf, Nathan R Foster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 20, 2021
Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes
Francesco Multinu, Simone Garzon, Amy L Weaver, et al.
Gynecologic Oncology
|
June 15, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes
Riham Suleiman, Shilpa Mokshagundam, Matthew S Block, et al.
Melanoma Research
|
June 24, 2011
Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine
Matthew S Block, Vera J Suman, Wendy K Nevala, et al.
Frontiers in Immunology
|
February 19, 2025
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Yuan Yao, Yiyi Yan, Vera J Suman, et al.
Page
of 12